» Articles » PMID: 7829075

Physical Mapping of Chromosome 17p13.3 in the Region of a Putative Tumor Suppressor Gene Important in Medulloblastoma

Overview
Journal Genomics
Specialty Genetics
Date 1994 Sep 1
PMID 7829075
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Deletion mapping of a medulloblastoma tumor panel revealed loss of distal chromosome 17p13.3 sequences in tumors from 14 of 32 patients (44%). Of the 14 tumors showing loss of heterozygosity by restriction fragment length polymorphism analysis, 14 of 14 (100%) displayed loss of the telomeric marker p144-D6 (D17S34), while a probe for the ABR gene on 17p13.3 was lost in 7 of 8 (88%) informative cases. Using pulsed-field gel electrophoresis, we localized the polymorphic marker (VNTR-A) of the ABR gene locus to within 220 kb of the p144-D6 locus. A cosmid contig constructed in this region was used to demonstrate by fluorescence in situ hybridization that the ABR gene is oriented transcriptionally 5' to 3' toward the telomere. This report provides new physical mapping data for the ABR gene, which has not been previously shown to be deleted in medulloblastoma. These results provide further evidence for the existence of a second tumor suppressor gene distinct from p53 on distal chromosome 17p.

Citing Articles

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients.

Sharbatoghli M, Fattahi F, Aboulkheyr Es H, Akbari A, Akhavan S, Ebrahimi M Front Genet. 2022; 13:938985.

PMID: 35938032 PMC: 9355329. DOI: 10.3389/fgene.2022.938985.


Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.

Ray S, Chaturvedi N, Bhakat K, Rizzino A, Mahapatra S Diagnostics (Basel). 2022; 12(1).

PMID: 35054230 PMC: 8774967. DOI: 10.3390/diagnostics12010061.


MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB).

Perumal N, Kanchan R, Doss D, Bastola N, Atri P, Chirravuri-Venkata R Acta Neuropathol Commun. 2021; 9(1):195.

PMID: 34922631 PMC: 8684142. DOI: 10.1186/s40478-021-01299-z.


MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).

Kanchan R, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel D Brain Pathol. 2020; 30(4):732-745.

PMID: 32145124 PMC: 7383594. DOI: 10.1111/bpa.12829.


miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer.

Ge P, Cao L, Chen X, Jing R, Yue W BMC Cancer. 2019; 19(1):1203.

PMID: 31823748 PMC: 6905032. DOI: 10.1186/s12885-019-6416-4.